Regulation of major histocompatibility class ii gene expression in frtl-5 thyrocytes: Opposite effects of interferon and methimazole

Endocrinology

Volumn 139, Issue 1, 1998, Pages 290-302

  Kohn, Leonard D ^a   Shong, Minho ^a,c,e   Taniguchi, Shinichi ^a,f   Suzuki, Koichi ^a   Giuliani, Cesidio ^a,g   Napolitano, Giorgio ^a,g   Saito, Jun ^a   Saji, Motoyasu ^a   Fiorentino, Bruno ^a   Reimold, Andreas M ^d   Singer, Dinah S ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e Chungnam National University College of Medicine   (South Korea)

^f TOTTORI UNIVERSITY   (Japan)

^g UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011463316     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.139.1.5658     Document Type: Article

References (75)

1. GermanRM, Malissen B1986 Analysis of the expression and function of class II major histocompatibility complex-encoded molecules by DNA-mediated gene transfer.Annu Rev Immunol4:281-315
2. TingJP-Y, BaldwinAS1993Regulation of MHC gene expression. Curr Opin Immunol5:8-16
3. SchwartzRS, DattaSK1989Autoimmunity and autoimmune diseases. In: Paul WE(ed) Fundamental Immunology. Raven Press, New York, pp 819-866
4. BottazzoGF, Pujol-BorrellR, HanafusaT, Feldmann M1983 Role of aberrant HLA-DR expression and antigen presentation in induction of thyroid autoimmunity. Lancet2:1115-1119
5. ToddI, LondeiM, Pujol-BorrellR, MirakianR, FeldmannM, BottazzoGF1986HLA-D/DR expression on epithelial cells: the finger on the trigger. Ann NY Acad Sci475:241-249
6. PiccininiLA, RomanSH, DaviesTF1987Autoimmune thyroid disease and thyroid cell class II major histocompatibility complex antigens. Clin Endocinol (Oxf). 26:253-272
7. SeetharamaiahGS, DesaiRK, DallasJS, TaharaK, KohnLD, PrabhakarBS1993Induction of TSH binding inhibitor immunoglobulins with the extracellular domain of the human thyrotropin receptor produced using a bacu-lovirus expression system. Autoimmunity14:315-320
8. CostagliolaS, AlcaldeL, RufJ, VassartG, LudgateM1994Overexpression of the extracellular domain of the thyrotropin receptor in bacteria; production of thyrotropin binding inhibiting immunoglobulins. J Mol Endocrinol13:11-21
9. CostagliolaS, AlcadeL, Tonacchera M 1994 Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunized with recombinant TSH-R. Biochem Biophys Res Commun 199:1027-1034
10. Costagliola S, Many MC, Stalmans-Falys M, Tonacchera M, Vassart G, Ludgate M 1994 Recombinant thyrotropin receptor and the induction of au- toimmune thyroid disease in BALB/c mice: a new animal model. Endocrinology135:2150-2159
11. MarionA, BraunJM, RoparsA, KohnLD, CharreireJ1994Induction of autoimmunity bv immunization of mice with human thyrotropin receptor. Cell Immunol158:329-341
12. WagleNM, DallasJS, SeetharamaiahGS, FanJL, DesaiRK, MemarO, RajaramanS, PrabhakarBS1994The induction of hyperthyroxinemia in BALB/c but not in several other strains of mice. Autoimmunity18:103-108
13. CarayanniotisG, HuangGC, NicholsonLB, ScottT, AllainP, McGregorAM, BangaJP1995Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease. Clin Exp Immunol99:294-302
14. SeetharamaiahGS, WagleNM, MorrisJC, PrabhakarBS1995Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding. Endocrinology136:2817-2824
15. WagleNM, PatibandlaSA, DallasJS, MorrisJC, PrabhakarBS1995Thyrotropin receptor-specific antibodies in BALB/CJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the immunoglobulin G1 subclass. Endocrinology136:3461-3469
16. VlaseH, NakashimaM, GravesPN, TomerY, MorrisJC, DaviesTF1995Defining the major antibody epitopes of the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology136:4415-4423
17. ShimojoN, KohnoY, YamaguchiK-I, KikuokaS-I, HoshiokaA, NiimiH, HiraiA, TamuraY, SaitoY, KohnLD, Tahara K1996 Induction of Graves'-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA93:11074-11079
18. BenoistC, MathisD1990Regulation of major histocompatibility complex class II genes: X, Y, and others letters of the alphabet. Annu Rev Immunol8:681-715
19. GlimcherLH, KaraCJ1992Sequences and factors: a guide to MHC class II transcription. Annu Rev Immunol10:13-49
20. ToddI, Pujol-BorrellR, HammondLJ, BottazzoGF, FeldmannM1985Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol61:265-273
21. PlatzerM, NeufeldDS, PiccininiLA, DaviesTF1987Induction of rat thyroid cell MHC class II antigen by thyrotropin and gamma interferon.Endocrinology121:2087-2092
22. MisakiT, TramontanoD, Ingbar S1988 Effects of rat gamma and non-gamma interferons on the expression of la antigen, growth, and differentiated functions of FRTL-5 cells. Endocrinology123:2849-2855
23. ZakarijaM, HomicekFJ, LevisS, MckenzieJM1988Effects of gamma interferon and tumor necrosis factor alpha on thyroid cells: induction of class II antigen and inhibition of growth stimulation. Mol Cell Endocrinol58:329-336
24. CooperDS1984Antithyroid drugs.N Engl J Med311:1353-1362
25. SingerDS, KohnLD, ZingerH, MozesE1994Methimazole can prevent development of disease in an experimental model of systemic lupus erythematosus. J Immunol153:873-880
26. ChanCC, GeryI, KohnLD, NussenblattRB, MozesE, SingerDS1995Periocular inflammation in mice with experimental systemic lupus erythematosus (SLE): a new experimental blepharitis and its modulation. J Immunol154:4830-4835
27. EliasAN, BarrRJ, RohanMK, Dangaran K 1995 Effect of orally administered antithyroid thioureylenes on PCNA and p53 expression in psoriatic lesions. Int J Dermatol34:280-283
28. SajiM, MoriartyJ, BanT, SingerDS, KohnLD1992MHC Class I expression in rat thyroid cells is regulated by hormones, methimazole, and iodide, as well as interferon. J Clin Endocrinol Metab75:871-878
29. KohnLD, WinandRJ1975Structure of an exophthalmos-producing factor derived from thvrotropin by partial pepsin digestion. J Biol Chem250:6503-6508
30. ReimoldAM, KaraCJ, RooneyJW, GlimcherLH1993Transforming growth factor β1 repression of the HLA-DRa gene is mediated by conserved proximal promoter elements. J Immunol151:4173-4182
31. ShimuraH, OkajimaF, IkuyamaS, ShimuraY, KimuraS, SajiM, KohnLD1994Thyroid-specific expression and cAMP autoregulation of the thyrotropin receptor gene involves thvroid transcription factor-1 (TTF-1). Mol Endocrinol8:1049-1069
32. DavisLG, DibnerMD, Battey JF 1986 Plasmid DNA preparation: Triton-lysozyme method. In: Basic Methods in Molecular Biologv. Elsevier, New York, pp 93-98
33. SangerF, NicklenS, CoulsonAR1977DNA sequencing with chain-termi-nating inhibitors. Proc Natl Acad Sci USA74:5463-5467
34. Ambesi-ImpiombatoFS1986Fast growing thyroid cell strain. U.S. patent 4:608, 341
35. KohnLD, ValenteWA, GrollmanEF, AlojSM, VittiP1986Clinical determination and/or quantification of thyrotropin and a variety of thyroid stimulatory or inhibitor factors performed in vitro with an improved cell line FRTL-5. U.S. patent 4:609, 622
36. GiulianiC, SajiM, NapolitanoG, PalmerLA, TaniguchiS-I, Shong M„SingerDS, Kohn LD1995Hormonal modulation of major histocompatibility complex class I gene expression involves an enhancer a-binding complex consisting of fra-2 and the p50 subunit of NF-kB. J Biol Chem270:11453-11462
37. SajiM, ShongM, NapolitanoG, PalmerLA, TaniguchiS-I, OhmoriM, OhtaM, SuzukiK, KirschnerS, GiulianiC, SingerDS, KohnLD1997Regulation of MHC class I gene expression in thyroid cells role of the cAMP response element-like sequence. J Biol Chem272:20096-20107
38. De WetJR, WoodKV, DeLucaM, HelinskiDR, SubramaniS1987Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol7:725-737
39. DignamJ, LebovitzR, Roeder R1983 Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res11:1475-1489
40. SambrookJ, FritschEF, ManiatisT1989 Molecular Cloning: a Laboratory Manual, ed 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 1123-1144
41. IkuyamaS, NillerHH, ShimuraH, AkamizuT, KohnLD1992Characterization of the 5'-flanking region of the rat thyrotropin receptor gene. Mol Endocrinol6:793-804
42. IkuyamaS, ShimuraH, HoefflerJP, KohnLD1992Role of the cyclic adenosine 3', 5’-monophosphate response element in efficient expression of the thyrotropin receptor promoter. Mol Endocrinol6:1701-1715
43. EhrlichR, SharrowS, MaguireJ, SingerD1989Expression of a class I MHC transgene: effects of in vivo a/p interferon treatment. Immunogenetics30:18-26
44. DaviesTF, YangC, PlatzerM1989The influence of antithyroid drugs and iodine on thyroid cell MHC class II antigen expression. Clin Endocrinol (Oxf)31:125-135
45. ReinhardtW, AppelMC, AlexS, YangXN, Braverman LE1989 The inhibitory effect of large doses of methimazole on iodine induced lymphocytic thyroiditis and serum thyroglobulin antibody titers in BB/Wor rats. J Endocrinol Invest12:559-563
46. DaviesTF, WeissI, GerberMA1984Influence of methimazole on murine thyroiditis. J Clin Invest73:397-404
47. HallengrenB, ForsgrenA, MelanderA1980Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab51:298-301
48. WeissI, DaviesTF1981Inhibition of immunoglobulin secreting cells by antithyroid drugs. J Clin Endocrinol Metab53:1223-1228
49. WeetmanAP, McGregorAM, HallR1983Methimazole inhibits thyroid autoantibody production by an action on accessor cells. Clin Immunol Im-munopathol28:39-45
50. WilsonR, McKilop JH, Chopra M, Thomson JA 1988 The effect of antithyroid drugs on B and T cell activity in vitro. Clin Endocrinol (Oxf)28:389-397
51. VolpeR, KarlssonA, JanssonP, DahlbergPA1986Evidence that antithyroid drugs induce remission in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol (Oxf)25:453-462
52. KohnLD, GiulianiC, MontaniV, NapolitanoG, OhmoriM, OhtaM, SajiM, SchuppertF, ShongM, SuzukiK, TaniguchiS-I, YanoK, SingerDS1995Antireceptor immunity. In: Rayner D, Champion B(eds) Thyroid Immunity. Landes, Austin/Georgetown, pp 115-170
53. SingerDS, KohnLD, MozesE, SajiM, WeissmanJ, NapolitanoG, LedleyFD1996Methods of assessing a candidate drug to suppress MHC class I expression and to be used to treat autoimmune diseases and transplant rejection. U.S. patent 5:556, 75
54. AriasJ, AlbertsA, BrindleP, ClaretF, SmealT, KarinM, FeramiscoJ, MontminyM1994Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature370:226-228
55. KeeBL, AriasJ, MontminyMR1996Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J Biol Chem271:2373-2375
56. BurmesterGR, JahnB, RohwerP, ZacherJ, WinchesterRJ, KaldenJR1987Differential expression of la antigens by rheumatoid synovial lining cells. J Clin Invest80:595-604
57. BottazzoGF, DeanBM, McNalllyJM, MacKayEH, SwiftPG, GambleDR1985In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med313:353-360
58. WeetmanAP, McGregorAM1994Autoimmune thyroid disease: further developments in our understanding. Endocr Rev15:788-830
59. AguayoJ, IitakaM, RowVV, VolpeR1988Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon gamma-induced HLA-DR expression. J Clin Endocrinol Metab66:903-908
60. AtwaMA, LukesYD, SalataK, Abo-HashemEM, El-KanishyMH, BuurmanKD1995The influence of triiodothyronine, thyroxine, thyrotropin, and me-thimazole on thyroid MHC class II expression. Clin Immunol Immunopathol76:209-213
61. CarelJC, RemyJJ, ZucmanD, SalameroJ, CharreireJ1986Role of methim-azole on DR antigen expression on human thyroid epithelial cell cultures. In: Drexhage HA, Weirsinga WA (eds) The Thyroid and Autoimmunity. Excerpta Medica, Amsterdam, pp 145-147
62. SchuppertF, TaniguchiS-I, SchrOderS, DralleH, von zur MilhlenA, KohnLD1996In vivo and in vitro evidence for iodide regulation of MHC class I and class II expression in human thyroid disease. J Clin Endocrinol Metab81:3622-3628
63. EguchiK, OtsuboT, KawarabeY, UekiY, FokudaT, MatsunagaM, Shi-momuraC, IshikawaN, TezudaH, HakaoH, ItoK, MorimotoC, NagatakiS1987The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease. Clin Exp Immunol70:403-410
64. OtsuboT, EguchiK, ShimomuraC, UekiY, TezudaH, IshikawaN, ItoK, NagatakiS1988In vitro cellular interactions among thyrocytes, T cells, and monocvtes from patients with Graves' disease. Acta Endocrinol (Copenh)117:282-288
65. LahatN, ScheinfeldM, SobelE, BaronE, KraiemZ1990Class II HLA-DR antigens on non-autoimmune human thyroid cells stimulate autologous T cells with high suppressor activity. Autoimmunity4:125-133
66. CoxPM, GodingCR1992An ATF/CREB binding motif is required for aberrant constitutive expression of the MHC class II DRa promoter and activation by SV40 T-antigen. Nucleic Acids Res20:4881-4887
67. ReithW, SteimleV, DurandB, KobrM, Mach B1995 Regulation of MHC class II gene expression.Immunobiology193:248-253
68. ShikamaN, LyonJ, La ThangueNB1997The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol7:230-236
69. LiouH-C, BoothbyMR, FinnPW, DavidonR, NabaviN, Zeleznik-LeNJ, TingJP-Y, GlimcherLH1990A new member of the leucine zipper-class of proteins that binds to the HLA DRa promoter. Science247:1581-1584
70. OnoSJ, LiouH-C, DavidonR, StromingerJL, GlimcherLH1991Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc Natl Acad Sci USA88:4309-4312
71. MontaniV, TaniguchiS-I, ShongM, SuzukiK, OhmoriM, GiulianiC, NapolitanoG, SajiM, FiorentinoB, ReimoldAM, TingJP-Y, KohnLD, SingerDS1998Major histocompatibility class II HLA-DRa gene expression in thyrocytes: counterregulation by class II transactivator and the thyroid Y box protein. Endocrinology139:280-289
72. Ohmori M, Shimura H, Shimura Y, Kohn LD 1996 A Y-box protein is a suppressor factor which decreases thyrotropin receptor (TSHR) gene expression. Mol Endocrinol 10:76-89
73. Ohmori M, Shong MH, Napolitano G, Singer DS, Kohn LD 1995 TSEP-1, a Y-box protein, is a negative regulator of major histocompatibility (MHC) class I, TSH receptor (TSHR) and MHC class II genes: it is a target of methimazole (MMI) action. Thyroid [Suppl] 15:37
74. Ting J P-Y, Painter A, Zeleznik-Le NJ, MacDonald G, Moore TM, Brown A, Schwartz BD 1994 YB-1 DNA-binding protein represses interferon 7 activation of class II major histocompatibility genes. J Exp Med 179:1605-1611
75. MacDonaldGH, Itoh-LindstromY, TingJP-Y1995The transcriptional regulatory protein, YB-1, promotes single-stranded regions in the DRA promoter. J Biol Chem270:3527-3533